retatrutide glp-1 gip glucagon receptor Retatrutide, a GIP, and agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA Retatrutide vs Tirzepatide (2026): Differences

Check out these 5 delicious fall crockpot recipes on the Blue Sky MD blog!

Diabetes is a disease that affects how your body uses insulin

Comprehensive reviews and guide to Blue Cross Blue Shield of Texas health insurance plans

And unlike existing addiction medications, which are prescribed by specialists and remain vastly underused, GLP-1 drugs are already prescribed at enormous scale by primary care doctors

Explore how GLP-1 medications are transforming weight loss by regulating appetite and supporting sustainable results

The Gallup Poll found that overall, use of semaglutide medicines or liraglutides doubled from nearly 6% in the first quarter of 2024 to over 12% in Q2 + Q3 in 2025